Novel Antiangiogenic Therapies for Renal Cell Cancer
نویسندگان
چکیده
منابع مشابه
Novel antiangiogenic therapies for renal cell cancer.
Renal cell cancer remains a disease for which highly effective therapy for the majority of patients with metastatic disease is lacking. The biology of clear cell carcinomas and their association with mutations of the von Hippel-Lindau gene and its resultant increased expression of vascular endothelial growth factor (VEGF) make angiogenesis a potentially pathophysiologic mechanism for tumor deve...
متن کاملNovel concepts of antiangiogenic therapies in metastatic renal cell cancer
The era of antiangiogenic drugs targeting the vascular endothelial growth factor (VEGF) signaling pathway has become a mainstay in the treatment of metastatic renal cell carcinoma (mRCC), showing primary responses in 65-70% of patients. Nevertheless, most of those patients progress to angiogenesis inhibitors over time due to different modes of resistance (adaptive and intrinsic). Both in vitro ...
متن کاملAntiangiogenic therapies in ovarian cancer
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the formation and progression of ovarian cancer. Several well-designed phase II and III trials studied the efficacy of antiangiogenic agents in advanced ovarian cancer. The results of these trials demonstrated significantly prolonged progression-free survival when antiangiogenic agents were used as a maintenance therap...
متن کاملAntiangiogenic therapies in ovarian cancer
Ovarian cancer is the fifth leading cause of cancer deaths among women and the leading cause of death from cancer of the gynecologic organs [1]. Often termed ‘the silent killer’, it usually produces no symptoms until it is in an advanced stage [2]. Few women have ovarian can‐ cer detected early and almost 75% of women diagnosed with ovarian cancer present at an advanced stage. Although the 5‐ye...
متن کاملNovel Cell-Based Therapies in Hepatic Disorders
In the recent decade, liver diseases with high mortality rate have became one of the major health problems worldwide. Liver transplantation is the most effective and the standard treatment for decompensated liver disease, but, shortage of available organs and inaccuracy in modeling of the liver diseases are the most limiting issues in treatment. Regenerative medicine and cell based therapy str...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2004
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-050007